CKD and Diabetes: Treatment and Prevention Update

Session Description:
The clinical entity of CKD and diabetes, encompasses DKD (diabetic kidney disease) and NDKD (nondiabetic kidney disease) or a combination of the two; diagnosis, disease management and research perspectives of these entities will be presented. Improved insights into the patho-mechanisms that are shared by these entities such as SGLT2 and RAASi. There will be some discussions on findings from clinical trials about new effective treatment in decreasing cardiovascular mortality and progression to end-stage renal disease. Prevention of kidney disease progression, regardless of aetiology is essential and will be discussed.

Learning Objectives:
An increased appreciation of associated CKD across different clinical settings. An increased awareness of novel drug class in cardiologists, diabetologists, nephrologists, and primary care physicians. An increased awareness of essential preventions in entities of diabetes and CKD.